Shui, Irene M.
Burcu, Mehmet
Shao, Changxia
Chen, Cai
Liao, Chi-Yin
Jiang, Shan
Cristescu, Razvan
Parikh, Ravi B. http://orcid.org/0000-0003-2692-6306
Article History
Received: 26 July 2023
Revised: 9 November 2023
Accepted: 17 November 2023
First Online: 6 December 2023
Competing interests
: IMS, MB, CS, CC and RC are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and are stockholders in Merck & Co., Inc., Rahway, NJ, USA. C-YL and SJ are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. RBP is a stockholder in Merck & Co., Inc., Rahway, NJ, USA, Google, GNS Healthcare, Onc.AI, and Thyme Care (ExternalRef removed), has a consultant or advisory role with Thyme Care, Humana, NanOlogy, and Merck & Co., Inc., received research funding from Humana, received travel expenses from the Oncology Institute of Hope and Innovation and holds intellectual property related to technology to integrate patient-reported outcomes into electronic health record algorithms.